TOLNAFTATE POWDER, U

The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) for the supply of 12 units of Tolnaftate Powder, USP, with a total contract value of $28.20. The award was issued on June 30, 2026, and the delivery is scheduled to be completed by the same date to the destination address listed as USS CANBERRA LCS 30, Unit 10047 Box 1, FPO AP 96694, United States. The contract specifies FOB Destination terms, meaning the contractor is responsible for all transportation costs and risks until the goods are delivered and accepted at the final location. Inspection and acceptance are conducted by the Government at the destination, with compliance required to USP standards and applicable Defense Federal Acquisition Regulation Supplement provisions. Payment will be made via the Defense Finance and Accounting Service in Columbus, Ohio, under the appropriation line 97X4930 5CBX 001 2620 S33189, and invoices must be submitted electronically in accordance with DFARS 252.232-7003, which typically mandates use of the Wide Area Workflow system. The contracting office is DLA Troop Support, Medical Supply Chain Pharm FSA in Philadelphia, Pennsylvania, with Shairy M. Cartagena acting as the local administrative point of contact. No options, extended delivery schedules, or additional line items are included, and the contract is a firm-fixed-price order with zero variance allowance. The CAGE code 1UNB0 confirms the awardee’s identity, but no socioeconomic certifications, small business status, or affirmative representations are documented. Packaging, marking, barcoding, and special requirements are not specified, and no formal clause listing, evaluation factors, or attachments section was provided in the available documentation.